跳至主要内容
临床试验/NCT04469400
NCT04469400已完成不适用

Study on Lifestyle Intervention for Patients With Impaired Glucose Regulation

Second Affiliated Hospital, School of Medicine, Zhejiang University8 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
116
试验地点
8
主要终点
Fasting blood glucose

研究概览

简要总结

Impaired glucose regulation (IGR) is closely related to overweight/obesity. By studying different dietary patterns (energy-limited diet vs. low-carbohydrate diet) and intensive lifestyle interventions combined with blood glucose monitoring, glucose regulation of overweight/obesity is affected. To improve the blood glucose and related metabolic indexes of patients with impaired (IGR), establish 1-2 clinical intervention programs for impaired glucose regulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-65 years old ② Fasting blood glucose is between 5.6-6.9 mmol/L (100-125mg/dL) or oral glucose tolerance test (OGTT) 2h plasma glucose (2h-PG) is 7.8-11.1 mmol/L (140-200 mg/dL)
  • 24 kg/m2 ≤ BMI ≤ 35 kg/m2
  • Those who are willing to accept assessment and sign informed consent.

排除标准

  • Patients diagnosed with diabetes or undergoing diabetes treatment;
  • Receiving drugs or surgery for weight loss at present or in the past 3 months;
  • Receiving corticosteroid or thyroid hormone treatment;
  • Secondary obesity caused by endocrine, genetic, metabolic and central nervous system diseases;
  • Patients with abnormal liver function (alanine aminotransferase or/and aspartate aminotransferase exceeding the upper limit of normal value 3 times); patients with abnormal renal function (serum creatinine exceeding the upper limit of normal value); suffering from kidney disease and other diseases that need to control protein intake;
  • Diseases affecting the digestion and absorption of food (such as chronic diarrhea, constipation, severe gastrointestinal inflammation, active gastrointestinal ulcer, gastrointestinal resection, cholecystitis/cholecystectomy, etc.); ⑦ Suffering from cardiovascular and cerebrovascular diseases, grade 3 hypertension, chronic hepatitis, malignant tumors, anemia, mental illness and memory disorders, epilepsy and other diseases; ⑧ Suffering from infectious diseases such as active tuberculosis and AIDS; ⑨ During pregnancy or lactation; ⑩Patients with physical disabilities and clinicians think it is not suitable to participate in the study (for example, have a serious disease not included in the discharge criteria) or are unwilling to participate in this study.

结局指标

主要结局

Fasting blood glucose

时间窗: ten weeks

Blood glucose 2 hours after meal

时间窗: ten weeks

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验